FDA Publishes Final Guidance for Small Entities Manufacturing HCT/Ps
The FDA clarifies its regulatory requirements for small entity establishments that manufacture human cells, tissues, or cellular or tissue-based products (HCT/P), in a final guidance released today.
Source: Drug Industry Daily